Experience of treating neuropsychiatric disorders with andaxine, tofranil and centredrine
- Authors: Mendelevich D.M.1
-
Affiliations:
- Kazan City Psychoneurological Dispensary of the Kazan Medical Institute
- Issue: Vol 45, No 2 (1964)
- Pages: 59-62
- Section: Articles
- URL: https://journals.rcsi.science/kazanmedj/article/view/58317
- DOI: https://doi.org/10.17816/kazmj58317
- ID: 58317
Cite item
Full Text
Abstract
In the last decade, a large number of new drugs have been introduced for the treatment of neuropsychiatric disorders, which has raised high expectations among doctors. Thus, the first reports on the use of phenothiazine drugs in psychiatric practice were encouraging. Not only the recently ill, but many patients, who had been incarcerated in psychiatric hospitals for years or decades and were considered "defective", that is, had irreversible mental changes, were in remission and discharged from hospitals after the use of neuroleptics. This gave rise to talk of a "new era in the treatment of mental illness".
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
D. M. Mendelevich
Kazan City Psychoneurological Dispensary of the Kazan Medical Institute
Author for correspondence.
Email: info@eco-vector.com
Russian Federation